Congress Asset Management CO Abbott Laboratories Transaction History

Congress Asset Management CO

$13.6 Billion
Q2 2024

A detailed history of Congress Asset Management CO transactions in Abbott Laboratories stock. As of the latest transaction made, Congress Asset Management CO holds 6,179 shares of ABT stock, worth $696,002. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,179

Previous 4,835 27.8%

Holding current value

$696,002

Previous $549,000 16.94%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$100.73 - $112.44 $135,381 - $151,119	1,344 Added 27.8%	6,179 $642,000
Q1 2024 Apr 11, 2024	SELL	$109.52 - $120.96 $229,225 - $253,169	-2,093 Reduced 30.21%	4,835 $549,000
Q4 2023 Mar 04, 2024	SELL	$90.19 - $110.4 $109,039 - $133,473	-1,209 Reduced 14.86%	6,928 $762,000
Q3 2023 Nov 01, 2023	SELL	$95.53 - $114.62 $71.7 Million - $86 Million	-750,166 Reduced 98.93%	8,137 $788,000
Q2 2023 Jul 27, 2023	SELL	$100.78 - $112.29 $1.3 Million - $1.45 Million	-12,936 Reduced 1.68%	758,303 $82.7 Million
Q1 2023 Apr 21, 2023	SELL	$96.86 - $114.01 $624,553 - $735,136	-6,448 Reduced 0.83%	771,239 $78.1 Million
Q4 2022 Jan 18, 2023	SELL	$95.06 - $111.52 $965,619 - $1.13 Million	-10,158 Reduced 1.29%	777,687 $0
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $5.14 Million - $5.95 Million	53,125 Added 7.23%	787,845 $76.2 Million
Q2 2022 Aug 02, 2022	SELL	$102.07 - $123.37 $8.3 Million - $10 Million	-81,317 Reduced 9.96%	734,720 $79.8 Million
Q1 2022 Apr 20, 2022	BUY	$114.02 - $139.04 $807,261 - $984,403	7,080 Added 0.88%	816,037 $96.6 Million
Q4 2021 Jan 28, 2022	SELL	$115.53 - $141.46 $11.3 Million - $13.8 Million	-97,395 Reduced 10.75%	808,957 $114 Million
Q3 2021 Nov 08, 2021	BUY	$116.66 - $129.06 $8.4 Million - $9.3 Million	72,026 Added 8.63%	906,352 $107 Million
Q2 2021 Aug 05, 2021	BUY	$105.79 - $124.53 $1.67 Million - $1.97 Million	15,819 Added 1.93%	834,326 $96.7 Million
Q1 2021 May 05, 2021	BUY	$108.84 - $128.23 $785,607 - $925,564	7,218 Added 0.89%	818,507 $98.1 Million
Q4 2020 Jan 26, 2021	BUY	$105.0 - $114.42 $1.47 Million - $1.61 Million	14,031 Added 1.76%	811,289 $88.8 Million
Q3 2020 Nov 03, 2020	BUY	$91.64 - $111.29 $936,927 - $1.14 Million	10,224 Added 1.3%	797,258 $86.8 Million
Q2 2020 Jul 23, 2020	BUY	$76.57 - $98.0 $1.51 Million - $1.94 Million	19,782 Added 2.58%	787,034 $72 Million
Q1 2020 Apr 21, 2020	BUY	$62.82 - $91.86 $611,615 - $894,348	9,736 Added 1.29%	767,252 $60.5 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $48,283 - $53,751	615 Added 0.08%	757,516 $65.8 Million
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $3,273 - $3,549	40 Added 0.01%	756,901 $63.3 Million
Q2 2019 Aug 07, 2019	BUY	$72.88 - $85.0 $1.24 Million - $1.44 Million	16,949 Added 2.29%	756,861 $63.7 Million
Q1 2019 May 08, 2019	BUY	$66.22 - $80.06 $2.6 Million - $3.14 Million	39,192 Added 5.59%	739,912 $59.1 Million
Q4 2018 Jan 25, 2019	BUY	$65.56 - $74.27 $39 Million - $44.2 Million	595,043 Added 563.08%	700,720 $50.7 Million
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $12,466 - $15,038	-205 Reduced 0.19%	105,677 $7.75 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $53,569 - $60,566	-952 Reduced 0.89%	105,882 $6.34 Million
Q4 2017 Jan 30, 2018	SELL	$53.68 - $57.47 $5,475 - $5,861	-102 Reduced 0.1%	106,834 $6.1 Million
Q3 2017 Oct 17, 2017	BUY	$48.06 - $53.64 $5.14 Million - $5.74 Million	106,936	106,936 $5.71 Million

Others Institutions Holding ABT

# of Institutions

3,137

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Account

Congress Asset Management CO Abbott Laboratories Transaction History